30th Annual Scientific Meeting (ASM) Trans Tasman Radiation Oncology Group (TROG) Cancer Research
Wrest Point Hotel CasinoHobart, USA Visit the Venue to read more
On behalf of the Trans Tasman Radiation Oncology Group (TROG Cancer Research), it is with pleasure that we invite you to our 30th Annual Scientific Meeting (ASM) in Hobart, Tasmania, Australia. The event will provide a unique opportunity for all health professionals with an interest in radiation oncology, to collectively discuss and influence the direction of current and future cancer clinical trials.
Our 2018 ASM celebrates 30 years since TROG Cancer Research began, so join us at the meeting and take part in our Subspecialty Group sessions, as well as full-day, interactive Research Workshops and take the opportunity to relax and network at our social afternoon, Welcome Function and Gala Dinner.
In 2018 TROG Cancer Research celebrates its 30th Anniversary and in those 30 years, TROG Cancer Research has been making a real difference through quality radiotherapy research. We are proud to be known as one of the highest recruiting collaborative trials group in Australia and New Zealand. Since our inception, over 13,500 people have volunteered to participate in more than 90 TROG clinical trials. We collaborate with over 200 hospitals and cancer centres throughout the world. Our organisation, consisting of over 1,400 Australian and international members, is made up of an extensive network of oncologists, radiation therapists, physicists, data managers and other researchers conducting research across a range of cancers.
Dr Neil Watkins
Position held: Petre Chair in Cancer Biology - Garvan Institute of Medical Research
The unifying goal of my research is to understand how aberrant activation of embryonic signalling pathways contributes to the initiation, growth and self-renewal of cancer. To achieve this goal, I have used a diverse range of model systems in several different tumor types to create a preclinical program that has made fundamental discoveries in cancer biology.
Professor Andreas Adam - Sponsored by Medtronic
Andreas Adam, CBE, MB, BS, DSc (Hon), PhD (Hon), FRCR, FRCP, FRCS, FACR (Hon), FRANZCR (Hon), FFR RCSI (Hon), FSIR, FBIR, EBIR, FMedSci
Andreas Adam is Professor of Interventional Radiology at the University of London and Clinical Director of Clinical Imaging and Medical Physics at Guy’s and St Thomas’s Hospital, London.
He trained in medicine at the Middlesex Hospital Medical School, after which he spent four years in internal medicine, cardiology and oncology. He then trained in radiology at the Royal Postgraduate Medical School, obtaining Fellowship of the Royal College of Radiologists. He is also a Fellow of the Royal College of Physicians and the Royal College of Surgeons. In 1992 he was appointed to the first professorial chair of interventional radiology in Europe, at King’s College London. In 2012 -2015 he served as Dean of the first state medical school in Cyprus.
His research work has shaped clinical practice internationally and has been recognised by the award of Fellowship of the Academy of Medical Sciences.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Wrest Point Hotel Casino,
410 Sandy Bay Rd,
Hobart, Tasmania, Australia 7005,
+61 3 6221 1888
As the TROG 2018 ASM is being held at Wrest Point, we have secured accommodation at the property for delegates to book. Room types and pricing are:
Tower Suite - $289 per night
Tower Standard Harbour View - $199 per night
Tower Standard Mountain View - $189 per night
Water Edge Room - $179 per night
Motor Inn Room - $159 per night
The TROG Annual Scientific Meeting will offer an educational and social experience that is both stimulating and entertaining to delegates.
Delegates will consist of radiation oncologists, medical physicists, radiation therapists, registrars, clinical trial coordinators, and statisticians from around Australia and New Zealand. Many delegates are TROG members, membership of which is held by the majority of radiation oncologists in Australia and New Zealand, as well as members from related oncology and clinical research disciplines. This will be a fantastic opportunity to get involved with your target market.
Contact No.: +61 2 401 43911